2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism - PubMed (original) (raw)
Comparative Study
. 2003 Jun 15;63(12):3413-7.
Affiliations
- PMID: 12810678
Comparative Study
2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism
Xiao Lin et al. Cancer Res. 2003.
Abstract
Exposure to ionizing radiation is believed to cause cell injury via the production of free radicals that are thought to induce oxidative damage. It has been proposed that exposure to agents that enhance oxidative stress-induced injury by disrupting thiol metabolism may sensitize cells to the cytotoxic effects of ionizing radiation. Recently, it has been shown that glucose deprivation selectively induces cell injury in transformed human cells via metabolic oxidative stress (J. Biol. Chem., 273: 5294-5299; Ann. N.Y. Acad. Sci., 899: 349-362), resulting in profound disruptions in thiol metabolism. Because 2-deoxy-D-glucose (2DG) is a potent inhibitor of glucose metabolism thought to mimic glucose deprivation in vivo, the hypothesis that exposure to 2DG might be capable of inducing radiosensitization in transformed cells via perturbations in thiol metabolism was tested. When HeLa cells were exposed to 2DG (4-10 mM) for 4-72 h, cell survival decreased (20-90%) in a dose- and time-dependent fashion. When HeLa cells were treated with 6 mM 2DG for 16 h before ionizing radiation exposure, radiosensitization was observed with a sensitizer enhancement ratio of 1.4 at 10% isosurvival. Treatment with 2DG was also found to cause decreases in intracellular total glutathione content (50%). Simultaneous treatment with the thiol antioxidant N-acetylcysteine (NAC; 30 mM) protected HeLa cells against the cytotoxicity and radiosensitizing effects of 2DG, without altering radiosensitivity in the absence of 2DG. Furthermore, treatment with NAC partially reversed the 2DG-induced decreases in total glutathione content, as well as augmented intracellular cysteine content. Finally, the cytotoxicity and radiosensitizing effects of 2DG were more pronounced in v-Fos-transformed versus nontransformed immortalized rat cells, and this radiosensitization was also inhibited by treatment with NAC. These results support the hypothesis that exposure to 2DG causes cytotoxicity and radiosensitization via a mechanism involving perturbations in thiol metabolism and allows for the speculation that these effects may be more pronounced in transformed versus normal cells.
Similar articles
- 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer.
Coleman MC, Asbury CR, Daniels D, Du J, Aykin-Burns N, Smith BJ, Li L, Spitz DR, Cullen JJ. Coleman MC, et al. Free Radic Biol Med. 2008 Feb 1;44(3):322-31. doi: 10.1016/j.freeradbiomed.2007.08.032. Epub 2007 Oct 16. Free Radic Biol Med. 2008. PMID: 18215740 - Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Andringa KK, Coleman MC, Aykin-Burns N, Hitchler MJ, Walsh SA, Domann FE, Spitz DR. Andringa KK, et al. Cancer Res. 2006 Feb 1;66(3):1605-10. doi: 10.1158/0008-5472.CAN-05-3462. Cancer Res. 2006. PMID: 16452219 - Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells.
Wu W, Abraham L, Ogony J, Matthews R, Goldstein G, Ercal N. Wu W, et al. Life Sci. 2008 May 23;82(21-22):1122-30. doi: 10.1016/j.lfs.2008.03.016. Epub 2008 Apr 3. Life Sci. 2008. PMID: 18448127 - Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
Dwarakanath BS. Dwarakanath BS. J Cancer Res Ther. 2009 Sep;5 Suppl 1:S27-31. doi: 10.4103/0973-1482.55137. J Cancer Res Ther. 2009. PMID: 20009290 Review. - Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
Farooque A, Afrin F, Adhikari JS, Dwarakanath BS. Farooque A, et al. J Cancer Res Ther. 2009 Sep;5 Suppl 1:S32-5. doi: 10.4103/0973-1482.55138. J Cancer Res Ther. 2009. PMID: 20009291 Review.
Cited by
- Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells.
Nile DL, Rae C, Walker DJ, Waddington JC, Vincent I, Burgess K, Gaze MN, Mairs RJ, Chalmers AJ. Nile DL, et al. Cancer Metab. 2021 May 19;9(1):24. doi: 10.1186/s40170-021-00258-5. Cancer Metab. 2021. PMID: 34011385 Free PMC article. - Metabolic response to radiation therapy in cancer.
Read GH, Bailleul J, Vlashi E, Kesarwala AH. Read GH, et al. Mol Carcinog. 2022 Feb;61(2):200-224. doi: 10.1002/mc.23379. Epub 2021 Dec 27. Mol Carcinog. 2022. PMID: 34961986 Free PMC article. Review. - Predicting response to radiotherapy of intracranial metastases with hyperpolarized [Formula: see text]C MRI.
Lee CY, Soliman H, Bragagnolo ND, Sahgal A, Geraghty BJ, Chen AP, Endre R, Perks WJ, Detsky JS, Leung E, Chan M, Heyn C, Cunningham CH. Lee CY, et al. J Neurooncol. 2021 May;152(3):551-557. doi: 10.1007/s11060-021-03725-7. Epub 2021 Mar 19. J Neurooncol. 2021. PMID: 33740165 Free PMC article. - Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways.
Meng W, Palmer JD, Siedow M, Haque SJ, Chakravarti A. Meng W, et al. Int J Mol Sci. 2022 Feb 17;23(4):2246. doi: 10.3390/ijms23042246. Int J Mol Sci. 2022. PMID: 35216362 Free PMC article. Review. - Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation.
Hasse FC, Koerber SA, Prigge ES, Liermann J, von Knebel Doeberitz M, Debus J, Sterzing F. Hasse FC, et al. Clin Transl Radiat Oncol. 2019 Aug 20;19:52-58. doi: 10.1016/j.ctro.2019.08.003. eCollection 2019 Nov. Clin Transl Radiat Oncol. 2019. PMID: 31517070 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- 1 K08 CA72602-01/CA/NCI NIH HHS/United States
- P01 CA66081/CA/NCI NIH HHS/United States
- P01 CA75556/CA/NCI NIH HHS/United States
- P20 CA91709/CA/NCI NIH HHS/United States
- R01 HL51469/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Other Literature Sources